The Applications of Psychedelic Assisted Therapy
This event is part of our Introduction to Psychedelic-assisted Therapy (PaT) Program's June 2023 Cohort.
This event is part of our Introduction to Psychedelic-assisted Therapy (PaT) Program's June 2023 Cohort.
The Client - Outcomes and Integration with Bruce Sanguin Live Q & A Access event
The SAP is a Health Canada program that allows individuals to receive psilocybin and MDMA assisted therapy when they have exhausted their search for relief for end-of-life distress, Major Depressive Disorders (MDD) and Post-Traumatic Stress Disorder (PTSD) without success.
Ketamine is an underutilized and lesser known psychedelic for practitioners looking to participate in the much anticipated revolution and legalization of psychedelic-assisted […]
Thursday October 26, 2023 @ 6:00 pm – 7:00 pm MST MAPS recently published the results of their Phase 3B MDMA […]
"Mastery of Experience" with Dr. Mark Atkinson Come and meet Dr. Mark Atkinson, internationally-renowned pioneer in the field of human potential development […]
Thursday November 16, 2023 @ 6:00 pm – 7:00 pm MST Ketamine possesses the potential to disrupt detrimental behavioral patterns, particularly those intertwined […]
Thursday December 7, 2023 @ 6:00 pm – 7:00 pm MDT Join our network and begin offering psychedelic-assisted therapy to much needed […]
Sponsored by ATMA, this webinar will help assist practitioners wishing to provide Psychedelic-assisted therapy (PaT). This webinar will answer these 2 important […]
Register Here Embarking on the journey to become an effective compassionate witness in the psychedelic realm is akin to transforming into […]
Register Here Join Dr. Scott Shannon (MAPS principal investigator on its Phase 3 MDMA Clinical Trial), and ATMA CEO, Vu Tran to learn more about […]
Register Here Join us for an exclusive fireside chat with the visionary team behind the Psychedelic Puppet Show while we come […]
